Adding relatively small transportation costs to an otherwise disease-specific, cost-effective environment does not make improved access to care non-cost-effective. For example, a congestive heart failure monitoring program that is already evaluated as highly cost-effective will not transition to cost-ineffective because of the addition of only incremental transportation costs.
Author
State
Not Available
Line of Business or Market
Not Available